Century Capital Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
Other funds holding XLRN
NHAS
EAM
PC
PA
Century Capital Management's XLRN Position: Q2 2017 in Review
Century Capital Management reduced its Acceleron Pharma (XLRN) stake by 17% in Q2 2017, selling an estimated $373K and leaving 60,778 shares worth $1.85M. The position accounts for 0.32% of the portfolio, ranked #111.
Century Capital Management first reported a position in XLRN in Q2 2016 and has held it in 5 quarters since. The position peaked at $5.15M in Q2 2016. 128 funds tracked by Wall St. Rank hold XLRN as of Q2 2017.
- Century Capital Management held 60,778 shares of Acceleron Pharma worth $1.85M as of Q2 2017.
- Century Capital Management sold 12,885 Acceleron Pharma shares in Q2 2017, an estimated $373K.
- Acceleron Pharma made up 0.32% of Century Capital Management's portfolio in Q2 2017, its #111 holding.
- Century Capital Management first reported a position in Acceleron Pharma in Q2 2016 and has held it in 5 quarters since.
- Century Capital Management's Acceleron Pharma position peaked at $5.15M in Q2 2016.
- 128 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2017.
Based on Century Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.